Takeover Talk Highlights Strong Prospects

Article Excerpt

BECKMAN COULTER INC. $72 (New York symbol BEC; Conservative Growth Portfolio, Manufacturing & Industry sector; Shares outstanding: 62.6 million; Market cap: $4.5 billion; WSSF Rating: Average) rose to $77 in July after a competitor accepted a takeover offer from Germany’s Siemens AG. Investors felt that Beckman, which has no controlling stockholder and a loyal customer base, would make an attractive target for a larger medical products company, or a conglomerate like General Electric. Regardless of takeover possibilities, Beckman continues to expand its sales and profits. In the second quarter of 2007, sales grew 11.9%, to $689.7 million from $616.3 million a year earlier. It earned $0.75 a share (total $47.8 million) before unusual items, up 8.7% from $0.69 a share ($43.8 million). Beckman spends around 9% of its sales of $41.60 a share on research, so it’s more profitable than it appears. Beckman is now selling more low-margin lab systems, which could hurt its profit growth. But that should spur demand for…